Synchronous and Metachronous Metastatic Breast Cancer, with Different Histology and Opposite Immunophenotype, Treated with Combination of Chemotherapy, Anti-Her2, and Endocrine Therapy: A Case Report

In the case of our patient, the synergic action of endocrine therapy and chemotherapy plus dual anti-HER2 combination allowed a complete disease control. Therapy should be scheduled by considering the two cancers as individual entities. The approach to breast cancer is changing from being considered...

Descripción completa

Detalles Bibliográficos
Autores principales: Megaro, Giacomina, Rossi, Luigi, Ceddia, Serena, Sinjari, Marsela, Mannino, Adele, Gozzi, Elisa, Cosimati, Antonella, Brandi, Martina, Bitca, Victoria, Toscani, Ilaria, Cimino, Giuseppe, Tomao, Silverio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275194/
https://www.ncbi.nlm.nih.gov/pubmed/32547382
http://dx.doi.org/10.1159/000507433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275194/
https://www.ncbi.nlm.nih.gov/pubmed/32547382
http://dx.doi.org/10.1159/000507433

Ejemplares similares